Collegium Pharmaceutical, Inc. COLL Interest Expense
Interest Expense at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s interest expense?
- Collegium Pharmaceutical, Inc. (COLL) reported interest expense of $15.86M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s interest expense changed year-over-year?
- Collegium Pharmaceutical, Inc.'s interest expense decreased by 23.7% year-over-year, from $20.79M to $15.86M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s interest expense?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s interest expense has grown at a 40.7% compound annual growth rate (CAGR), from $21.01M to $82.31M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.